| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |